M. Kneussl (Vienna, Austria), T. Kuriyama (Chiba, Japan)
Long-term continuous subcutaneous treprostinil therapy for pulmonary arterial hypertension (PAH)
N. Skoro-Sajer, E. Harja, D. Bonderman, S. Rezaie-Majd, S. Machherndl, M. Kneussl, I. M. Lang (Vienna, Austria)
|  |
Infusion of iloprost induces a significant increase in exhaled NO in SSc patients
L. Ronchi, M. R. Pozzi, M. Robuschi (Monza, Italy)
| |
Inhaled iloprost for patients with portopulmonary hypertension
M. Halank, C. Marx, S. Usicenko, C. Opitz, J. Winkler, R. Ewert, G. Hoeffken (Dresden, Berlin, Leipzig, Greifswald, Germany)
| |
The incidence of chronic thromboembolic pulmonary hypertension (CTEPH): a 25-year population-based study
W. F. Dunn, J. A. Heit, S. A. Farmer, T. M. Petterson, K. V. Ballman (Rochester, United States Of America)
| |
Thrombin-antithrombin (TAT) complexes in pulmonary hypertension
P. Jansa, M. Sidova, H. Spundova, Z. Susa, M. Aschermann (Prague, Czech Republic)
| |
Comparison between semiquantitative and quantitative measurements of D-dimers for the diagnosis of pulmonary embolism
G. C. Maglaras, N. Kolaitis, C. Koumbaniou, Z. Metafratzi, S. Giotopoulou, G. Vartholomatos, M. P. Vassiliou, S. H. Constantopoulos (Ioannina, Greece)
| |
Combination of inhaled nitric oxide and an endothelinA-receptor antagonist in acute pulmonary thromboembolism
S. D. Lee, W. S. Kim, D. S. Kim, W. D. Kim, J. H. Lee (Seoul, South Korea)
| |
Association of clinical characteristics with HLA in chronic thromboembolic pulmonary hypertension
N. Tanabe, A. Kimura, S. Amano, O. Okada, Y. Kasahara, Y. Takiguchi, K. Tatsumi, M. Takahashi, H. Shibata, M. Yasunami, T. Kuriyama (Chiba, Tokyo, Japan)
| |
Serum levels of TIMP-1 and TIMP-2 are elevated in patients with pulmonary hypertension
L. Stiebellehner, N. Broks, V. Petkov, G. Funk, K. Vonbank, P. Schenk, R. Ziesche, L. H. Block (Vienna, Austria)
| |
Influence of inhaled nitric oxide on plasma endothelin-1 in pulmonary hypertension
P. Schenk, V. Fuhrmann, I. Lang, L. Stiebellehner, V. Petkov, K. Ratheiser, O. F. Wagner (Vienna, Austria)
| |
Patients with primary or thromboembolic pulmonary hypertension develop renal resistance to ANP and BNP
A. Charloux, A. Chaouat, F. Piquard, G. Brandenberger, S. Doutreleau, E. Weitzenblum (Strasbourg, France)
| |
Endoglin germline mutation, hereditary hemorrhagic telangiectasia and fenfluramine-associated pulmonary arterial hypertension
A. Chaouat, F. Coulet, G. Simonneau, E. Weitzenblum, F. Soubrier, M. Humbert (Strasbourg, Paris, Clamart, France)
| |
6MWD in patients with pulmonary arterial hypertension (PAH)
V. S. Probst, T. Troosters, I. Coosemans, F. Pitta, M. A. Spruit, A. Debrock, R. Gosselink, M. Delcroix, M. Decramer (Leuven, Belgium)
| |
Spontaneous hemodynamic variability in pulmonary hypertension
I. P. Kolos, I. E. Chazova, A. N. Samko, N. A. Mironova, T. V. Martynyuk (Moscow, Russia)
| |
Regional right ventricular function versus hemodynamics in pulmonary arterial hypertension: an ultrasonic strain and strain rate study
V. Dambrauskaite, P. Claus, G. R. Sutherland, M. Delcroix (Leuven, Belgium)
| |
The diastolic function in patients with obstructive and restrictive pulmonary diseases
I. B. Shutckaya, A. Y. Gichkin, V. E. Perley, A. L. Alexandrov (St Petersburg, Russia)
| |
The b -2 adrenoreceptor Gln27Glu gene polymorphism could play role in high-altitude pulmonary hypertension
A. A. Aldashev, O. A. Pak, E. V. Kim, T. M. Sooronbaev, B. K. Kojonazarov, M. M. Mirrakhimov, M. R. Wilkins, N. W. Morrell (Bishkek, Kyrgyzstan; London, United Kingdom)
| |
Prevalence of pulmonary hypertension in limited and diffuse scleroderma
N. Karoli, A. Rebrov (Saratov, Russia)
| |
Incidence of pulmonary hypertension in hyperthyroidism
M. Marvisi, C. Ajolfi, R. Delfrate, R. Lampugnani, R. Delsignore (Fiorenzuola d'Arda, Parma, Italy)
| |
The prevalence of pulmonary hypertension in cirrhotic patients submitted to hepatic transplantation
E. Garcia, A. I. Zille, J. S. Moreira, C. A. Marroni, G. P. Cantisani (Porto Alegre, Brazil)
| |